
The annual BHF conference is taking place in Cape Town from 14 -17 May 2023. Networking, collaboration and learning about emerging healthcare issues, innovation and industry action, and discussions regarding what’s next.
Recent Posts

Enhancing Tuberculosis Outcomes Through Counselling Incentives
Tuberculosis counselling incentives that combine conditional cash transfers with structured pre- and post-test counselling are proving highly effective at overcoming socioeconomic barriers to treatment adherence. This integrated strategy reduces long-term disease transmission while requiring only...

NICE Guidance on Mirvetuximab Ovarian Cancer Treatment
Mirvetuximab ovarian cancer treatment has taken a major step forward after NICE recommended mirvetuximab soravtansine for adults with folate receptor-alpha positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who have received one to three...

Exploring Immunotherapy for Liver Cancer through the EMERALD-3 Trial
Immunotherapy for liver cancer has advanced substantially with the EMERALD-3 Phase III trial, which showed that